Patterns of treatment-related adverse events and treatment discontinuation in phase III oncology clinical trials.
466 Background: Treatment-related adverse events (TRAEs) are a common cause of discontinuation in cancer clinical trials. Although TRAEs are routinely documented, the relative contributions of patients (pts), clinicians, and protocol-mandated requirements to these decisions remain poorly characterized. We sough...